
Key facts at a glance
The headline numbers on regain. How fast it starts, where it plateaus, and why it's biology, not willpower.

> 500,000 patients
> 33,000 reviews
Ongoing clinical support
Regulated by CQC
4.6 Trustpilot rating
Regulated by CEDR
No hidden costs
> 500,000 patients
> 33,000 reviews
Ongoing clinical support
Regulated by CQC
4.6 Trustpilot rating
Regulated by CEDR
No hidden costs

All content on this page has been medically reviewed by: Hassan Thwaini, Clinical Pharmacist and Copywriter, Master of Pharmacy (MPharm) on 7 March, 2026. GPhC Registration: 2221320View profile
If you've stopped a weight loss programme (or you're thinking about it), weight regain is a real risk. But it's not inevitable. The research shows that with the right support, you can take meaningful steps to protect your progress.
Let's see what actually happens when you stop, and what you can do about it.

Key facts at a glance
The headline numbers on regain. How fast it starts, where it plateaus, and why it's biology, not willpower.

The full research
What the studies actually say about weight regain after Mounjaro and Wegovy and why the picture is more hopeful than "you'll gain it all back."

The emotional side of weight regain
Why regain can feel like failure, how emotional cycles drive it further, and why reframing the process is the first step to breaking the pattern.

Managing appetite and food noise
How to handle the return of food noise after stopping medication — including the mindful eating techniques with the strongest evidence behind them.

How to prevent weight regain
The three things research suggests matter most after stopping: behavioural support, nutrition strategy, and resistance training.
/)
Real stories, one year on
What lasting change actually looks like — three Numan patients on life after completing the programme.
Regain typically starts fast
After stopping, people regain an average of 0.8kg based on a 2026 Oxford meta-analysis of 37 studies and 9,341 adults.¹
It doesn't go on forever
Most people regain around 60% of lost weight within a year, then it plateaus, meaning around 25% of loss is sustained.²
Weight regain after stopping is a key driver of restarting treatment
Clear link between weight regain and going back on medication — the more weight someone regained after stopping, the more likely they were to restart.³
18 months to starting weight without help
Without intervention, research projects a return to starting weight at roughly 18 months.¹
Behavioural support can reduce regain fourfold
Structured programmes can reduce the rate of regain by approximately four times compared to stopping medication alone.⁴
It's biology, not willpower
Regain is driven by appetite hormones and metabolic adaptation, not a lack of effort on your part.
Research shows that most people regain some weight after stopping GLP-1 medications. A 2026 study found people regain approximately 0.8kg per month after stopping, with most returning to their pre-treatment weight within 18 months without support.¹ Another study added that regain can plateau, and roughly 25% of weight lost may be sustained long-term.² The picture is more hopeful than "you'll gain it all back."
What the evidence also shows is that regain after medication is around four times faster than after behavioural programmes.³ The reason is straightforward: GLP-1s suppress appetite for you. When you stop, that support ends, and if you haven't yet built the habits to replace it, the body defaults back to what it knows.

Here's why it happens and what you can do about it.
When you lose weight, your body fights back, adjusting hunger and satiety hormones to drive weight back up. This biological response is why stopping medication without building new habits in place makes regain more likely.¹
GLP-1 medications reduce hunger and increase satiety, meaning weight loss can happen without conscious changes to eating habits. When the medication stops, those signals return, often before sustainable habits have had a chance to form.¹
The best window to build sustainable habits is while your appetite is already suppressed, not after you stop. In a small preliminary study presented at the European Congress on Obesity, patients who gradually tapered their medication while receiving coaching on diet and exercise maintained a stable weight for 26 weeks after stopping entirely.9
The evidence is clear on what happens when you stop but it's also clear on what helps. Here's what the research suggests you can do about it.

Regain begins almost immediately after stopping. The transition off medication needs a plan, not just a decision. Research shows most patients who discontinued hadn't been on treatment long enough to reach full results, with an average treatment duration of just six months.¹

Patients who maintained behavioural changes after stopping (such as following a carbohydrate-restricted diet) experienced significantly less weight regain than average.² The medicated phase is your best window to build these foundations.

Up to 45% of weight lost on GLP-1s may be lean mass.⁵ Since each kilogram of muscle lost reduces your resting metabolic rate by around 13 kcal/day, preserving muscle during treatment helps protect your metabolism.⁵ Resistance training is one of the most effective strategies to minimise this.

Structured programmes reduce the rate of regain by approximately four times compared to stopping medication alone.⁴ This isn't anecdotal, it's one of the clearest findings in the data.

Cardiometabolic gains — blood sugar, blood pressure, cholesterol — reverse within around 1.4 years of stopping.¹ If you have existing metabolic conditions, that timeline matters for how you plan your treatment.
Stopping weight loss medication doesn't mean starting over. Understanding what's likely to happen — physically and emotionally — puts you back in control.

The honest answer: yes, most people regain some weight after stopping, but it's rarely all of it, and it doesn't happen overnight.
Individual outcomes vary widely, and some people maintain their results entirely after stopping.² Two things appear to make the biggest difference: continuing healthy eating habits (particularly keeping carbohydrates lower) and tapering off the medication gradually rather than stopping abruptly.¹
The medication works best as a foundation. What you build on it, in terms of habits and behaviours, shapes what happens next.

Weight regain can feel like failure. It isn't. Research shows that over half of people who regain weight attribute it to emotional reasons — most commonly stress and turning to food for comfort.6 These aren't character flaws. They're predictable responses that affect the majority of people in the same situation.
Recognising this pattern is the first step to breaking it. Regain driven by emotional eating is a well-documented physiological and psychological process — not a personal failing. Reframing it that way isn't just kinder; the evidence suggests it's also more effective.6
Obesity is a chronic, relapsing condition. NICE recommends structured support for a minimum of 12 months after stopping.⁷ The best time to prepare for life after medication is while you're still on it.
People who lost weight through behavioural programmes regained it more slowly than those who stopped medication, suggesting that the habits built during treatment may matter as much as the treatment itself.4
Behavioural support
On medication, weight loss can happen without conscious effort, meaning many patients haven't practised the habits that sustain it. Coaching during treatment builds those skills, and people who developed stronger behavioural foundations regained weight more slowly after stopping.¹
Nutrition strategy
What you eat after stopping matters as much as how much. People who maintained a lower-carbohydrate diet after stopping GLP-1 medication experienced significantly less regain than average.¹ The medication window is the best time to establish eating patterns you can sustain.
Resistance training
Up to 45% of weight lost on GLP-1s may be lean mass.⁴ Since muscle drives your resting metabolic rate, losing it makes regain faster and harder to reverse. Resistance training during treatment helps preserve it.⁴
One of the most commonly reported challenges after stopping GLP-1 medication is the return of "food noise," that persistent mental preoccupation with eating that the medication had quietened. For many patients, this is the hardest part of the transition.
Mindful eating techniques have good evidence for reducing emotional eating and eating in response to external cues, both of which drive food noise.⁸ The core skill is learning to distinguish genuine physical hunger from emotional or habitual triggers. Eating slowly and without distraction has been shown to improve awareness of fullness and reduce overall food intake.⁸
The evidence is clearest for preventing weight gain rather than driving active weight loss, which makes mindful eating particularly well-suited to the post-cessation period, when the goal is holding onto progress rather than continuing to lose.⁸
Building these habits while your appetite is still suppressed, during treatment rather than after, gives you a significant head start.
/)




At Numan, medication doesn't work in isolation. Our weight loss programme combines GLP-1 treatment with coaching and clinical oversight — designed to build the skills you'll need after medication stops.
Our published study of patients who engage with the full Numan obesity programme, including health coaching, lose 27% more weight in the first 9 months than those who do not.10 The difference isn't just about numbers on the scale. Patients who engaged with coaching built the habits, knowledge, and self-awareness that give them a better foundation for maintaining results after medication ends.
Personalised coaching
Nutrition, exercise, mindset, sleep. Your coach works with you to build the habits that transfer to life after medication — not just the ones that help during treatment.
App-based tracking
Progress monitoring, medication reminders, clinician messaging in the app. So nothing falls through the cracks.
Transition planning
Our coaches assess readiness and build personalised maintenance plans. The goal: no one transitions off medication without a clear strategy for what comes next.
Helen came to Numan feeling disconnected from herself — avoiding mirrors, avoiding being seen. The programme was what she calls “the reprogramming bit”: rebuilding her relationship with her body while the medication did its part. A year on, the shift goes well beyond the physical.
“It’s been a wonderful year. I can’t believe I waited so long to start living my life. I just wish I’d done it sooner.”
“I’ve done the reprogramming bit. Now I get to live my life having had that help. I feel better in myself — I’m not scared to look in the mirror.”

Sarah’s starting point wasn’t dramatic — low confidence, low energy, a sense she could feel better. As a mum with young children, she’d deprioritised herself for years. What surprised her was how the changes spread: the nutrition guidance reshaped how the whole household ate, not just her own plate.
“Confidence was low, energy was low. I just didn’t feel as happy as I could be. Now that’s changed.”
“I feel like I’m bouncing up the hill on the school run, whereas before I’d wonder why I was doing this. The whole household eats differently now.”

Craig didn't want a number on the scale — he wanted his life back. Camping, hiking, turning up to DJ gigs in shirts he hadn't worn in 20 years. Two years after finishing the programme, he's got all of it.
He credits building habits alongside medication, so when the treatment ended, the changes were already embedded.
“I’ve been two years away from it now and I feel the healthiest I’ve felt for years and years.”
“I go out camping now. I do all sorts. I’ve got shirts I hadn’t worn for 20 years and I get to wear them at gigs again.”

West S, Koutoukidis D, et al. Weight regain after cessation of anti-obesity medications: a systematic review and meta-analysis. The BMJ. January 2026. University of Oxford. 37 studies, 9,341 adults.
University of Cambridge. Weight regain trajectories after GLP-1 receptor agonist cessation. eClinicalMedicine. 2025.
Rodriguez PJ, Zhang V, Gratzl S, et al. Discontinuation and Reinitiation of Dual-Labeled GLP-1 Receptor Agonists Among US Adults With Overweight or Obesity. JAMA Netw Open. 2025;8(1):e2457349
National Institute for Health and Care Research (NIHR). Slimming injections linked to faster weight regain than traditional dieting. NIHR News, 2026. https://www.nihr.ac.uk/news/slimming-injections-linked-faster-weight-regain-traditional-dieting
Neeland IJ, Linge J, Birkenfeld AL. Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies. Diabetes Obes Metab. 2024;26(S4):16-27.
Sainsbury, K., Evans, E. H., Pedersen, S., Marques, M. M., Teixeira, P. J., Lähteenmäki, L., Stubbs, R. J., Heitmann, B. L., & Sniehotta, F. F. (2019). Attribution of weight regain to emotional reasons amongst European adults with overweight and obesity who regained weight following a weight loss attempt. Eating and Weight Disorders, 24(2), 351–361. https://doi.org/10.1007/s40519-018-0487-0
National Institute for Health and Care Excellence. (2025). Overweight and obesity management: Quality standard QS212. NICE. https://www.nice.org.uk/guidance/qs212
Warren, J. M., Smith, N., & Ashwell, M. (2017). A structured literature review on the role of mindfulness, mindful eating and intuitive eating in changing eating behaviours: effectiveness and associated potential mechanisms. Nutrition Research Reviews, 30(2), 272–283. https://doi.org/10.1017/S0954422417000154
Presented at the 2024 European Congress on Obesity. Semaglutide dose tapering with lifestyle coaching.
Griffiths, et al. (2025). Impact of Engagement on Weight Loss Outcomes with Tirzepatide and a Digital Health Programme. Conference abstract.
Medically reviewed: